Dr. Dana Zappetti, MD

Dr. Zappetti practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Zappetti's NPI, 1538259700, was assigned on October 16, 2006. Dr. Zappetti graduated from The Warren Alpert Medical School of Brown University in 1999. Dr. Zappetti holds New York license 222600.

Dr. Zappetti's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Zappetti's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Zappetti to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zappetti practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Zappetti's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Zappetti is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Zappetti's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, hypersomnia and pleural effusion among the conditions Dr. Zappetti treats.

CMS data shows 635 Medicare services from Dr. Zappetti across 10 procedure codes in 2024, for 403 Medicare patients. Medicare paid $63,426 for them.

CMS counts 403 Medicare patients who saw Dr. Zappetti in 2024. The largest group is 75 to 84, with 169 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zappetti's median patient age at 66, with 63% women.

In 2024, Dr. Zappetti wrote 1,571 Medicare Part D claims for 241 patients. 32% of them were for generic drugs. CMS names the drug for 1,396 of them, across 31 drugs with 11 or more claims each, at $549,441 in total drug cost. In 2023, CMS named 1,268 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Zappetti for performance year 2024, reported through an alternative payment model (APM). Dr. Zappetti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zappetti as offering telehealth.

Dmand AI links 9 papers to Dr. Zappetti, published from 2015 to 2023. 2015 was the busiest year, with 3. The most frequent topics are Coronavirus Infections, Hematopoietic Stem Cell Transplantation and Respiratory Tract Infections. Dr. Zappetti's most frequent co-authors are Tsiporah B. Shore, MD, Michael Joseph Satlin, MD and Rosemary Soave, MD.

CMS Open Payments shows 24 general payments to Dr. Zappetti from 11 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $114.

Dmand AI lists 1 award for Dr. Zappetti, most recently CMS Stage 1 EHR in 2013.

Dr. Zappetti graduated from The Warren Alpert Medical School of Brown University in 1999.

Dr. Zappetti is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.